This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring both an amine and a hydroxyl group, makes it a versatile building block for developing drugs targeting the central nervous system, particularly in the creation of dopamine receptor agonists or antagonists. It is also explored in the development of potential treatments for neurological disorders such as Parkinson’s disease and schizophrenia. Additionally, its chemical properties make it suitable for use in research applications, including the study of receptor-ligand interactions and the development of novel therapeutic agents.